Arytmogenne działanie propafenonu — opis przypadku

Abstract

Propafenone is used in the therapy of supraventricular arrhythmias. Its long-term use may be associated with the development of malignant ventricular arrhythmias. We present a case of a patient with paroxysmal atrial fibrillation, who was administered an oral dose of 600 mg of propafenone, which resulted in an episode of ventricular tachycardia. This article indicates that patients without severe heart failure subjected to therapeutic doses of propafenone are also exposed to the possibility of its adverse effects.